Robin Swartz

COO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VYGR

Current role

COO

2026-05-08–present

1 call Latest call 2024-05-13

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Voyager Therapeutics, Inc. (VYGR)	Chief Business Officer & Chief Operating Officer	$520,190	—	$300,675	$414,675	$205,475	$13,285	$1,454,300
2024	Voyager Therapeutics, Inc. (VYGR)	Chief Business Officer & Chief Operating Officer	$490,745	—	$380,000	$528,000	$199,534	$15,525	$1,613,804

Earnings-call appearances and filed executive appointments or departures, newest first.